Sanesco Sanesco Health International is a biomedical company providing healthcare practitioners with clinical tools and products used for neuroendocrine health. | ![]() Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine. | ![]() Chinook Therapeutics Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases. | ![]() Phoenix Nest Phoenix Nest is a biotech company that provides treatment for the disease Sanfilippo syndrome. | ![]() ImmusanT ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases. | |
Founding Date | Founding Date 2004 | Founding Date 2004 | Founding Date 2011 | Founding Date 2012 | Founding Date 2010 |
Type | Type Private | Type Public | Type Subsidiary | Type Private | Type Private |
Tags | |||||
Locations | Locations Arden, US HQ | Locations Melbourne, AU HQ Singapore, SG New York, US | Locations Seattle, US HQ | Locations New York, US HQ | Locations Cambridge, US HQ |
Employees | Employees 23 | Employees 73 | Employees 27 | Employees 10 | Employees 2 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $17.2m (FY, 2025) | Revenue (est.) $6.1m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($102.1m) (FY, 2025) | Net income ($187.9m) (FY, 2022) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 56.2m | Total funding raised $ 171m | Total funding raised N/A | Total funding raised $ 72.8m |

Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine.
View company
Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases.
View company
Phoenix Nest is a biotech company that provides treatment for the disease Sanfilippo syndrome.
View company
ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases.
View company